SE9502927D0 - Solution containing IGF-I - Google Patents

Solution containing IGF-I

Info

Publication number
SE9502927D0
SE9502927D0 SE9502927A SE9502927A SE9502927D0 SE 9502927 D0 SE9502927 D0 SE 9502927D0 SE 9502927 A SE9502927 A SE 9502927A SE 9502927 A SE9502927 A SE 9502927A SE 9502927 D0 SE9502927 D0 SE 9502927D0
Authority
SE
Sweden
Prior art keywords
solution containing
solution
containing igf
igf
stable
Prior art date
Application number
SE9502927A
Other languages
Swedish (sv)
Inventor
Jonas Fransson
Dan Hallen
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9502927A priority Critical patent/SE9502927D0/en
Publication of SE9502927D0 publication Critical patent/SE9502927D0/en
Priority to AU68415/96A priority patent/AU6841596A/en
Priority to PCT/SE1996/001041 priority patent/WO1997007816A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a stable solution containing Insulin-like Growth Factor I (IGF-I) or any functional analogue thereof as active agent and mannitol in a pH adjusted solution, optionally with a preservative. There should be no sodium chloride. This solution is physically stable without giving any precipitates, it is isotonic and suitable for injection.
SE9502927A 1995-08-24 1995-08-24 Solution containing IGF-I SE9502927D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9502927A SE9502927D0 (en) 1995-08-24 1995-08-24 Solution containing IGF-I
AU68415/96A AU6841596A (en) 1995-08-24 1996-08-22 Solution containing igf-i
PCT/SE1996/001041 WO1997007816A1 (en) 1995-08-24 1996-08-22 Solution containing igf-i

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9502927A SE9502927D0 (en) 1995-08-24 1995-08-24 Solution containing IGF-I

Publications (1)

Publication Number Publication Date
SE9502927D0 true SE9502927D0 (en) 1995-08-24

Family

ID=20399261

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9502927A SE9502927D0 (en) 1995-08-24 1995-08-24 Solution containing IGF-I

Country Status (3)

Country Link
AU (1) AU6841596A (en)
SE (1) SE9502927D0 (en)
WO (1) WO1997007816A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436897B2 (en) * 1998-06-01 2002-08-20 Celtrix Pharmaceuticals, Inc. Pharmaceutical formulations for IGF/IGFBP
CA2378949C (en) * 1999-07-12 2015-03-31 Grandis Biotech Gmbh Growth hormone formulations
WO2020004368A1 (en) 2018-06-25 2020-01-02 Ｊｃｒファーマ株式会社 Protein-containing aqueous liquid formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
CA2489978A1 (en) * 1992-07-31 1994-02-17 Genentech, Inc. Human growth hormone aqueous formulation
SE9300105D0 (en) * 1993-01-15 1993-01-15 Kabi Pharmacia Ab STABLE PROTEIN SOLUTION

Also Published As

Publication number Publication date
WO1997007816A1 (en) 1997-03-06
AU6841596A (en) 1997-03-19

Similar Documents

Publication Publication Date Title
DE69531314D1 (en) USE OF METALION CHELATORS FOR THE STABILIZATION OF INTERFERON-CONTAINING PHARMACEUTICAL PREPARATIONS
ATE197895T1 (en) AGENTS FOR ARTIFICIAL BROWNING WITH IMPROVED COLOR DEVELOPMENT
DE69924232D1 (en) STABILIZED INSULIN PREPARATIONS
MY125556A (en) Aqueous formulations of peptide
ATE133181T1 (en) DEHYDRODIDEMNINE B
DK1288223T3 (en) Therapeutic peptide derivatives
HRP20020198B1 (en) Moxifloxacin formulation containing common salt
EP1329461B8 (en) Method of eliminating human serum albumin polymers
SE9502927D0 (en) Solution containing IGF-I
DE69007546D1 (en) Hair treatment composition.
DK0523406T3 (en) Use of low pH tri (n-butyl) phosphate in solutions of biologically active proteins for enhanced virucidal action
MX9605280A (en) Stabilization of non-halogenates 3-isothiazolones in aggressive systems.
TR199701335T1 (en) Diatomaceous earth pest composition
ATE179075T1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS CONTAINING DOBUTAMINES
UA43797A (en) Injection form of the preparation, which manifests the anti-ischemic activity
NO930711D0 (en) AMINO ACID DERIVATIVES CIRCULATED AT THE C-TERMINAL END
SU1536770A1 (en) CHLORIDE BENZYLHEXAMETHYLENETHRAMMONIUM, HAS BACTERICIDAL ACTIVITY IN RESPECT OF SULFATER RESTORING BACTERIA AND PSEUDOMONAS CULTURES
ITFE930013U1 (en) MECHANIZED ORIENTAL STICKS.
IT1253704B (en) Stable therapeutic solutions for injectable use
GT199200002A (en) AMINO ACID DERIVATIVES